Led · Seed · Mar 2022

BioCoach develops healthtech tools and resources aimed at enabling individuals to take control of their metabolic health. The company applies cutting-edge biotechnology alongside data-driven insights to improve metabolic outcomes. The announcement highlights BioCoach's mission to revolutionize how people manage their health at scale. There are no operating metrics or revenue figures reported in the article. The company recently received external financing in the form of a working-capital facility. The financing relationship was framed as support for BioCoach’s continued operations and growth. BioCoach offers direct-to-consumer in-vitro diagnostic testing and is launching an integrated at-home health management system that includes coaching, data analytics and integrations with Walmart and Apple Health. The company recently received FDA 510(k) clearance for a next-generation glucose and ketone monitoring system. BioCoach positions its platform to help people assess and take control of metabolic health conditions such as obesity, diabetes and prediabetes. Leadership emphasizes consumer empowerment and simplifying healthy living. The seed funding will be used to scale its new digital health platform and expand its affiliated brands. The company communicates a mission-driven stance against entrenched healthcare incumbents in the U.S.